Frank A Sinicrope

Trials

Studies that name Frank A Sinicrope as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:05 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07143487 · Family Communications After Genetic Testing

  Alliance for Clinical Trials in Oncology · recruiting · Colon Adenocarcinoma, Colorectal Adenocarcinoma, Rectal Adenocarcinoma · study chair
• Ph3
  NCT02912559 · Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

  National Cancer Institute (NCI) · active not recruiting · Colon Adenocarcinoma, DNA Repair Disorder, Lynch Syndrome · principal investigator
• Ph2
  NCT00983580 · Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

  National Cancer Institute (NCI) · completed · Adenomatous Polyp · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Integration of Genomic and Clinical Data to Enhance Subtyping of Colon Cancer
  R01CA210509 · NCI · MAYO CLINIC ROCHESTER · fiscal years 2017 to 2021 · $407,754 awarded in 2021
  Same name and institution; not confirmed by an ID
• Polyphenon E for the Chemoprevention of Colorectal Cancer
  R01CA132991 · NCI · MAYO CLINIC ROCHESTER · fiscal years 2008 to 2013 · $1 awarded in 2013
  Same name and institution; not confirmed by an ID
• Translational Research in Colon Cancer Prevention & Treatment
  K05CA142885 · NCI · MAYO CLINIC ROCHESTER · fiscal years 2009 to 2013 · $162,001 awarded in 2013
  Same name and institution; not confirmed by an ID
• Aberrant Crypt Foci as a Biomarker for Chemoprevention
  R01CA113681 · NCI · MAYO CLINIC ROCHESTER · fiscal years 2006 to 2009 · $670,480 awarded in 2009
  Grant number is on one of their registry trials
• Clinical Significance of Apoptosis in Colon Cancer
  R01CA104683 · NCI · MAYO CLINIC ROCHESTER · fiscal years 2003 to 2006 · $253,773 awarded in 2006
  Same name and institution; not confirmed by an ID
• BETA-CATENIN AND RAR INTERACT AT THE PKC ALPHA PROMOTER
  R01DK056378 · NIDDK · MAYO CLINIC ROCHESTER · fiscal years 2002 · $186,362 awarded in 2002
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Alliance for Clinical Trials in Oncology Member Site Core
  U10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026
  Named on NCT02912559
• Pathology Research Shared Resource
  P30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI THOMAS J FLOTTE · fiscal years 2014 to 2026
  Named on NCT00983580